New Key Statistics Module, Z-Score and F-Score
NAS:RNAC Key Ratios
Market Cap $ M | 294.01 |
Enterprise Value $ M | 221.65 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 2.37 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 54.00 |
EPS (TTM) $ | -53.46 |
Beneish M-Score | 11.09 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.90 |
EV-to-EBITDA | -0.90 |
PEG | -- |
Shares Outstanding M | 21.38 |
Net Margin (%) | -424.47 |
Operating Margin % | -90.55 |
Pre-tax Margin (%) | -459.59 |
Quick Ratio | 4.78 |
Current Ratio | 4.78 |
ROA % (ttm) | -93.85 |
ROE % (ttm) | -- |
ROIC % (ttm) | -28.07 |
Dividend Yield % | -- |
Altman Z-Score | -4.11 |
RNAC Number of Guru Trades
RNAC Volume of Guru Trades
Gurus Latest Trades with NAS:RNAC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RNAC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cartesian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RNAC
Total 0- 1